A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1997
12/30/1997	CA2134964C Bridged aza-bicyclic derivatives as substance p antagonists
12/30/1997	CA2102282C Polymeric antimicrobials and their use in pharmaceutical compositions
12/30/1997	CA2085231C Process for the preparation of shaped, compressed controlled-release unit-dosage forms, and the compressed unit-dosage forms thus obtained
12/30/1997	CA2071629C Use of insulin sensitizing agents to treat hypertension
12/30/1997	CA2067863C Medicine for the treatment of illnesses of the respiratory organs
12/30/1997	CA2060833C Analgesic composition containing ibuprofen
12/30/1997	CA2030237C Method and means for treating alcoholism by extinguishing the alcohol-drinking response using a transdermally administered opiate antagonist
12/30/1997	CA2024479C Quinone derivatives and pharmacological use
12/30/1997	CA2021529C N,n'-bis(alkoxyalkyl)-pyridine-2,4-dicarboxylic acid diamides, preparation and their use
12/30/1997	CA1339609C 2-substituted-4-substituted-1, 3-dioxolanes, synthesis and use thereof
12/29/1997	EP0814087A2 Partially lyophilized fructose-1,6-diphosphate (FDP) for injection into humans
12/29/1997	EP0814084A1 Indole derivatives as 5-HT1A antagonists and as inhibitors of serotonine reuptake
12/29/1997	EP0814081A1 Drug resistance and multidrug resistance modulators
12/29/1997	EP0814080A1 Squalene synthetase inhibitors
12/29/1997	EP0814077A1 Benzoylguanidines, process for their preparation and medicaments containing them
12/29/1997	EP0813904A2 Process for preparing salts of acid groups containing pharmaceutical actives
12/29/1997	EP0813878A1 Lacrimation accelerating agent containing a serotonin ligand, especially aminoalkoxybibenzyl compounds
12/29/1997	EP0813877A2 Method for treating congestive heart failure
12/29/1997	EP0813875A2 Inhibition of abnormal accumulation of extracellular matrices
12/29/1997	EP0813874A1 Remedy for pancreatitis
12/29/1997	EP0813873A1 Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors
12/29/1997	EP0813872A1 Berberine derivates for inhibiting hsp27 production
12/29/1997	EP0813871A1 Berberine derivates for inhibiting production of HSP47
12/29/1997	EP0813870A1 Use of darifenacin to enhance cognitive functions
12/29/1997	EP0813869A1 Use of strontium salts for the treatment of arthritis
12/29/1997	EP0813868A2 Retroviral protease inhibitors
12/29/1997	EP0813867A2 Retroviral protease inhibitors
12/29/1997	EP0813866A2 Therapeutic agent for joint diseases
12/29/1997	EP0813865A1 Drug patch
12/29/1997	EP0813863A2 A method for the preparation of stable aqueous suspensions, useful in pharmaceutical compositions
12/29/1997	EP0813595A1 Stimulation of meiosis
12/29/1997	EP0813545A1 Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon
12/29/1997	EP0813542A1 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
12/29/1997	EP0813539A1 Improved process for the synthesis of 2'-o-substituted pyrimidines and oligomeric compounds therefrom
12/29/1997	EP0813537A1 Phosphorylated nitrone derivatives, method for preparing same, and compositions containing said derivatives
12/29/1997	EP0813536A1 Process for the preparation of pharmaceutically acceptable salts of clavulanic acid
12/29/1997	EP0813535A1 Hexacyclic camptothecin analogues, and process for preparing them
12/29/1997	EP0813534A1 6-ARYL PYRAZOLO 3,4-d]PYRIMIDIN-4-ONES AND COMPOSITIONS AND METHODS OF USE THEREOF
12/29/1997	EP0813533A1 SUBSTITUTED N-CYCLOALKYLMETHYL-1H-PYRAZOLO 3,4-b]QUINOLIN-4 AMINES AND COMPOSITIONS AND METHODS OF USE THEREOF
12/29/1997	EP0813532A1 PREPARATION OF CHIRAL 5-AMINOCARBONYL-5H-DIBENZO- a,d]CYCLOHEPTEN-5,10-IMINES BY OPTICAL RESOLUTION
12/29/1997	EP0813531A1 Antitumour isocoumarins
12/29/1997	EP0813529A1 Arginine analogues having nitric oxide synthase inhibitor activity
12/29/1997	EP0813527A1 6-SUBSTITUTED PYRAZOLO 3,4-d] PYRIMIDIN-4-ONES AND COMPOSITIONS AND METHODS OF USE THEREOF
12/29/1997	EP0813524A1 Indole derivatives as eaa antagonists
12/29/1997	EP0813520A1 Arylsulfonylamino hydroxamic acid derivatives
12/29/1997	EP0813519A1 Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
12/29/1997	EP0813424A1 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate
12/29/1997	EP0813423A1 Composition to ameliorate osteolysis and metastasis
12/29/1997	EP0813422A1 Compositions and methods for stimulating antibody class switching
12/29/1997	EP0813418A2 Composition for treating skin conditions comprising an inhibitor of skin iso-phosphodiesterase
12/29/1997	EP0813417A1 Use of hyaluronic acid for the treatment of interstitial cystitis
12/29/1997	EP0813416A1 Reduction of infarct volume using citicoline
12/29/1997	EP0813414A1 Combination of bisphosphonates and growth hormone secretagogues
12/29/1997	EP0813413A1 Corticosteroid-containing pharmaceutical composition
12/29/1997	EP0813412A1 Gel for the local hormonotherapy of vaginal dryness
12/29/1997	EP0813411A1 Use of vinpocetine derivatives for inhibiting production or secretion of amyloid beta protein
12/29/1997	EP0813410A1 SUBSTITUTED N-ARYLMETHYL AND HETEROCYCLYLMETHYL-1H-PYRAZOLO 3,4-b]QUINOLIN-4-AMINES AND COMPOSITIONS AND METHODS OF USE THEREOF
12/29/1997	EP0813409A1 Treatment of cytokine growth factor caused disorders
12/29/1997	EP0813408A1 Growth stimulating factors
12/29/1997	EP0813407A1 Liquid aqueous pharmaceutical compositions comprising sodium alginate and potassium bicarbonate
12/29/1997	EP0813403A1 Stable water-in-oil emulsion system
12/29/1997	EP0771195A4 Method of inhibiting nitric oxide formation
12/29/1997	EP0764026A4 Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders
12/29/1997	EP0731711B1 Dialysis fluid containing peptides obtained from casein as osmotic agents and bicarbonate ions as buffering agents
12/29/1997	EP0719264B1 Imidazolone and oxazolone derivatives as dopamine antagonists
12/29/1997	EP0705270B1 Chemically modified oligonucleotide for site-directed mutagenesis
12/29/1997	EP0665744B1 Stable extended release oral dosage composition
12/29/1997	EP0660715B1 Carbostyril derivatives as antiarrhythmic agents
12/29/1997	EP0656775B1 Sustained release tablets containing bupropion
12/29/1997	EP0655928B1 Use of an homeopathic product for the manufacture of a medicament for treatment of metabolic diseases
12/29/1997	EP0648120B1 Use of phosphonates for the treatment of osteoporosis
12/29/1997	EP0603303B1 Antimicrobial compositions containing propylene carbonate and/or ethylene carbonate as the carrier solvent
12/29/1997	EP0569564B1 Biphenylylquinuclidines, useful as squalene synthetase inhibitors
12/28/1997	CA2209430A1 Cosmetic and/or dermatological acid composition containing one cross-linked poly(2-acrylamido 2-methylpropane sulfonic acid) polymer neutralized to at least 90%
12/26/1997	CA2208652A1 Pharmaceutical compounds
12/24/1997	WO1997048805A1 HUMAN THYMOSIN β15 GENE, PROTEIN AND USES THEREOF
12/24/1997	WO1997048803A1 Human protein kinase c inhibitor homolog
12/24/1997	WO1997048802A1 HUMAN cAMP-DEPENDENT PROTEIN KINASE INHIBITOR HOMOLOG
12/24/1997	WO1997048801A2 Polynucleotides encoding secreted proteins
12/24/1997	WO1997048724A2 Human metabotropic glutamate receptor
12/24/1997	WO1997048713A1 Macrocyclic 13-membered ring derivatives of erythromycins a and b
12/24/1997	WO1997048711A1 Dendrimers based on saccharides
12/24/1997	WO1997048700A1 Indoline derivatives useful as 5-ht-2c receptor antagonists
12/24/1997	WO1997048699A1 Indoline derivatives useful as 5-ht-2c receptor antagonists
12/24/1997	WO1997048698A1 Compounds having effects on serotonin-related systems
12/24/1997	WO1997048697A1 Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase
12/24/1997	WO1997048696A1 Pyridyl alkene- and pyridyl alkine- acid amides as cytostatics and immunosuppressives
12/24/1997	WO1997048695A1 New pyridyl alkane acid amides as cytostatics and immunosuppressives
12/24/1997	WO1997048694A1 Compounds and methods for providing pharmacologically active preparations and uses thereof
12/24/1997	WO1997048693A1 Isocoumarin derivatives and use thereof in drugs
12/24/1997	WO1997048691A1 Ring-fused dihydropyranes, process for the preparation and use thereof
12/24/1997	WO1997048689A1 Drug resistance and multidrug resistance modulators
12/24/1997	WO1997048687A1 Process for the preparation of chiral keto-heterocycles of basic amino acids
12/24/1997	WO1997048683A1 Substituted benzamide derivatives and their use as anticonvulsants
12/24/1997	WO1997048682A1 Heterocyclylmethylamino derivatives of cyclobutene-3,4-diones as potassium channel modulators
12/24/1997	WO1997048681A1 Sulphonamide derivatives and their use in the treatment of cns disorders
12/24/1997	WO1997048680A1 Methanesulphonate salt of an arylpiperazine derived from tryptamine and its solvates for pharmaceutical use
12/24/1997	WO1997048674A1 Diaryl antimicrobial agents
12/24/1997	WO1997048672A2 Substituted tetrahydronaphthalene and dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
12/24/1997	WO1997048444A1 Iontophoretic delivery of cell adhesion inhibitors

1 ... 6708 6709 6710 6711 6712 6713 6714 6715 6716 6717 6718 6719 6720 6721 6722 6723 6724 6725 6726 6727 6728 ... 7860